https://www.statnews.com/2023/07/17/vyvgart-cipd-argenx-chronic-inflammatory-demylinating-polyneuropathy/
0
0
7/16/23 at 10:03pm
Organization
STAT
Author
Adam Feuerstein
25 words
0
Comments
Argenx's antibody treatment, Vyvgart, significantly delayed the progression of an autoimmune nerve disorder called CIPD.
You are the first to view
Create an account
or login to join the discussion